Cited by 1,763Cardiac pacing and defibrillation studiesCardiac Arrest and ResuscitationHeart Failure Treatment and Management

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Open access

Køber, Lars, Thune, Jens J., Nielsen, Jens C., Haarbo, Jens, Videbæk, Lars, Korup, Eva, Jensen, Gunnar, Hildebrandt, Per, Steffensen, Flemming H., Bruun, Niels E., Eiskjær, Hans, Brandes, Axel, Thøgersen, Anna M., Gustafsson, Finn, Egstrup, Kenneth, Videbæk, Regitze, Hassager, Christian, Svendsen, Jesper H., Høfsten, Dan E., Torp-Pedersen, Christian, Pehrson, Steen·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1608029

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The benefit of an implantable cardioverter-defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT). METHODS: In a randomized, controlled trial, 556 patients with symptomatic systolic heart failure (left ventricular ejection fraction, ≤35%) not caused by coronary artery disease were assigned to receive an ICD, and 560 patients were assigned to receive usual clinical care (control group). In both groups, 58% of the patients received CRT. The primary outcome of the trial was death from any cause. The secondary outcomes were sudden cardiac death and cardiovascular death. RESULTS: After a median follow-up period of 67.6 months, the primary outcome had occurred in 120 patients (21.6%) in the ICD group and in 131 patients (23.4%) in the control group (hazard ratio, 0.87; 95% confidence interval [CI], 0.68 to 1.12; P=0.28). Sudden cardiac death occurred in 24 patients (4.3%) in the ICD group and in 46 patients (8.2%) in the control group (hazard ratio, 0.50; 95% CI, 0.31 to 0.82; P=0.005). Device infection occurred in 27 patients (4.9%) in the ICD group and in 20 patients (3.6%) in the control group (P=0.29). CONCLUSIONS: In this trial, prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease was not associated with a significantly lower long-term rate of death from any cause than was usual clinical care. (Funded by Medtronic and others; DANISH ClinicalTrials.gov number, NCT00542945 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1608029

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A. H., Dyer, A. R., Daubert, J. P., Quigg, R. J., Estes, N. A. M., Anderson, K. P., Calkins, H. G., Hoch, D., Goldberger, J. J., Shalaby, A. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,078
Reduction in Inappropriate Therapy and Mortality through ICD Programming
Moss, A. J., Schuger, C. D., Beck, C. A., Brown, M. W., Cannom, D. S., Daubert, J. P., Estes, N. A. M., Greenberg, H., Hall, W. J., Huang, D. T.-C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211107 · Cited by 1,369

Flagged first, then by citations

Show all 18 references

Sorted by citations

Items 401–500 of 999

Echocardiographic Longitudinal Strain Analysis in Heart Failure: Real Usefulness for Clinical Management Beyond Diagnostic Value and Prognostic Correlations? A Comprehensive Review
Sanna, G. D., Canonico, M. E., Santoro, C., Esposito, R., Masia, S. L., Galderisi, M., Parodi, G., & Nihoyannopoulos, P. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00530-1 · Cited by 21
Herzinsuffizienzleitlinien 2021 der ESC
Bauersachs, J. K., & Soltani, S. (2021) · Herz · doi:10.1007/s00059-021-05084-5 · Cited by 21
Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy
Cittar, M., Cipriani, A., Merlo, M., Vitrella, G., Masè, M., Carrer, A., Barbati, G., Belgrano, M., Pagnan, L., Lazzari, M. D., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.765274 · Cited by 20
Role of Implantable Cardioverter Defibrillator in Heart Failure With Contemporary Medical Therapy
Butler, J., Talha, K. M., Aktaş, M. K., Zaręba, W., & Goldenberg, I. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.122.009634 · Cited by 20
Impact of late gadolinium enhancement extent, location, and pattern on ventricular tachycardia and major adverse cardiac events in patients with ischemic vs. non-ischemic cardiomyopathy
Tat, E., Ball, C., Camren, G. P., Wroblewski, I., Dajani, K. A., Goldberg, A., Kinno, M., Sanagala, T., Syed, M., Wilber, D. J., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1026215 · Cited by 20
Artificial Intelligence in Ventricular Arrhythmias and Sudden Death
Holmström, L. T. A., Zhang, Z., Ouyang, D., Dey, D., Slomka, P. J., & Chugh, S. S. (2023) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2022.42 · Cited by 21
Sex Differences in the Clinical Presentation and Natural History of Dilated Cardiomyopathy
Owen, R., Buchan, R. J., Frenneaux, M. P., Jarman, J. W. E., Baruah, R., Lota, A. S., Halliday, B. P., Roberts, A. M., İzgi, C., Spall, H. G. C. V., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.10.009 · Cited by 24
Sudden Death in Obesity
Holmström, L. T. A., Junttila, J. M., & Chugh, S. S. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.09.016 · Cited by 23
Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator
Martens, P., Verbrugge, F. H., Nijst, P., Dupont, M., Nuyens, D., Herendael, H. V., Rivero‐Ayerza, M., Tang, W. H. W., & Müllens, W. (2017) · Heart · doi:10.1136/heartjnl-2017-311423 · Cited by 20
Current Therapeutic Options for Heart Failure in Elderly Patients
Guerra, F., Brambatti, M., Matassini, M. V., & Capucci, A. (2017) · BioMed Research International · doi:10.1155/2017/1483873 · Cited by 22
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates
Levy, W. C., Hellkamp, A. S., Mark, D. B., Poole, J. E., Shadman, R., Dardas, T., Anderson, J., Johnson, G. W., Fishbein, D. P., Lee, K. L., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.04.015 · Cited by 20
The impact of implantable cardioverter-defibrillator implantation on health-related quality of life in the DANISH trial
Bundgaard, J. S., Thune, J. J., Nielsen, J. C., Videbæk, R., Haarbo, J., Bruun, N. E., Videbæk, L. M., Aagaard, D., Korup, E., Jensen, G. V. H., et al. (2019) · EP Europace · doi:10.1093/europace/euz018 · Cited by 19
Self-citation
Several reasons explained the variation in the results of 22 meta-analyses addressing the same question
Khamis, A. M., Moheb, M. N. E., Nicolas, J., Iskandarani, G., Refaat, M. M., & Akl, E. A. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.05.023 · Cited by 20
Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions
Reddy, Y. N. V., Borlaug, B. A., O’Connor, C. M., & Gersh, B. J. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz364 · Cited by 22
Sudden cardiac death in chronic renal disease: aetiology and risk reduction strategies
Pickup, L. C., Law, J. P., Townend, J., & Ferro, C. J. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz232 · Cited by 20
Cardiac Imaging With 123I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives
Wan, N., & Travin, M. I. (2020) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.03.001 · Cited by 20
Mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention
Gras, M., Bisson, A., Bodin, A., Herbert, J., Babuty, D., Pierre, B., Clémenty, N., & Fauchier, L. (2020) · EP Europace · doi:10.1093/europace/euaa096 · Cited by 20
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach
Fabris, E., Merlo, M., Rapezzi, C., Ferrari, R., Metra, M., Frigerio, M., & Sinagra, G. (2019) · Drugs · doi:10.1007/s40265-019-01181-2 · Cited by 22
Carotid baroreceptor stimulation suppresses ventricular fibrillation in canines with chronic heart failure
Wang, J., Dai, M., Cao, Q., Yu, Q., Luo, Q., Shu, L., Zhang, Y., & Bao, M. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0750-1 · Cited by 20
Powerlessness of a Number
Wu, K. C., & Calkins, H. G. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.005519 · Cited by 20
Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death
Kutyifa, V., Vermilye, K., Daimee, U. A., McNitt, S. A., Klein, H., & Moss, A. J. (2018) · EP Europace · doi:10.1093/europace/euy091 · Cited by 19
Rationale and Design of the EU-CERT-ICD Prospective Study: Comparative Effectiveness of Prophylactic ICD Implantation
Zabel, M., Sticherling, C., Willems, R., Lubiński, A., Bauer, A., Bergau, L., Braunschweig, F., Brugada, J., Brusich, S., Conen, D., et al. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12367 · Cited by 19
Self-citation
Long‐term follow‐up of Chagas heart disease patients receiving an implantable cardioverter‐defibrillator for secondary prevention
Pavão, M. L. R. C., Arfelli, E., Filho, A. S., Rassi, A., Pazin‐Filho, A., Pavão, R. B., Marin‐Neto, J. A., & Schmidt, A. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13333 · Cited by 19
CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy international registry: Design and rationale of the DERIVATE study
Guaricci, A. I., Masci, P. G., Lorenzoni, V., Schwitter, J., & Pontone, G. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.043 · Cited by 19
Sacubitril/valsartan or an implantable cardioverter-defibrillator in heart failure with reduced ejection fraction patients: a cost-effectiveness analysis
Zacà, V. (2018) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000708 · Cited by 19
Syndecan-1 as an independent risk factor for the incidence of adverse cardiovascular events in patients having stage C and D heart failure with non-ischemic dilated cardiomyopathy
Liu, W., Wang, Y., Zheng, J., Song, D., Zheng, S., Ren, L., Wang, Y., Yao, Y., Wang, Y., Liu, Y., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.12.022 · Cited by 19
Arrhythmogenic Inflammatory Cardiomyopathy in Autoimmune Rheumatic Diseases: A Challenge for Cardio-Rheumatology
Mavrogeni, S. I., Markousis‐Mavrogenis, G., Aggeli, C., Tousoulis, D., Kitas, G. D., Kolovou, G. D., Iliodromitis, E. K., & Sfikakis, P. P. (2019) · Diagnostics · doi:10.3390/diagnostics9040217 · Cited by 19
Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study
Waks, J. W., Haq, K. T., TOMPKINS, C. M., Rogers, A. J., Ehdaie, A., Bender, A. B., Minnier, J., Dalouk, K. A., Howell, S. J., Peiris, A., et al. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.03.006 · Cited by 19
EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)
Chazova, I. E., Shestakova, M. V., Zhernakova, Y. V., Blinova, N. V., Маркова, Т. Н., Mazurina, N. V., Владиславович, Е. М., Tereshchenko, S. N., Жиров, И. В., Komarov, A. L., et al. (2021) · Eurasian heart journal · doi:10.38109/2225-1685-2021-2-6-61 · Cited by 19
Strain echocardiography improves prediction of arrhythmic events in ischemic and non-ischemic dilated cardiomyopathy
Melichova, D., Nguyen, T. M., Salte, I. M., Klæboe, L. G., Sjøli, B., Karlsen, S., Dahlslett, T., Leren, I. S., Edvardsen, T., Brunvand, H., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.07.044 · Cited by 19
Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta‐analysis
Akel, T., & Lafferty, J. (2017) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12253 · Cited by 19
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond
Zaher, W., Rocca, D. G. D., Pannone, L., Bovéda, S., de Asmundis, C., Chierchia, G., & Sorgente, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051316 · Cited by 18
Cardiac Resynchronization Therapy for Heart Failure
Ojo, A. O., Tariq, S., Harikrishnan, P., Iwai, S., & Jacobson, J. T. (2017) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2017.03.010 · Cited by 21
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle
Porcari, A., Luca, A. D., Grigoratos, C., Biondi, F., Faganello, G., Vitrella, G., Nucifora, G., Aquaro, G. D., Merlo, M., & Sinagra, G. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09986-0 · Cited by 17
Wearable Cardioverter-Defibrillator: Friend or Foe in Suspected Myocarditis?
Blaschke, F., Lacour, P., Dang, P. L., Parwani, A. S., Hohendanner, F., Walter, T., Klingel, K., Kühl, U., Heinzel, F. R., Sherif, M., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13340 · Cited by 18
Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis
Patel, D. R., Kumar, A., Black‐Maier, E., Morgan, R. L., Trulock, K. M., Wilner, B. R., Nemer, D. M., Donnellan, E., Tarakji, K. G., Cantillon, D. J., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008991 · Cited by 18
CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter–Defibrillator in Non-Ischemic Cardiomyopathy
Keil, L. D., Chevalier, C. M., Kirchhof, P. F., Blankenberg, S., Lund, G., Müllerleile, K., & Magnussen, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137115 · Cited by 18
State of the art: multimodality imaging in dilated cardiomyopathy
Halliday, B. P. (2022) · Heart · doi:10.1136/heartjnl-2022-321116 · Cited by 18
Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone‐Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis
Manolis, A. S., & Melita, H. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12996 · Cited by 18
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathy
Merlo, M., Masè, M., Vitrella, G., Belgrano, M., Faganello, G., Giusto, F. D., Boscutti, A., Gobbo, M., Gigli, M., Altinier, A., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.04.017 · Cited by 18
Evaluation and management of ventricular tachycardia in patients with dilated cardiomyopathy
Ebert, M., Richter, S., Dinov, B., Zeppenfeld, K., & Hindricks, G. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.10.028 · Cited by 18
Major Reduction in the Risk of Sudden Cardiac Death in Patients with Chronic Heart Failure with the Use of Drug and Device Combinations that Favourably Affect Left Ventricular Structure
Packer, M. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1501 · Cited by 18
3D Electrophysiological Modeling of Interstitial Fibrosis Networks and Their Role in Ventricular Arrhythmias in Non-Ischemic Cardiomyopathy
Balaban, G., Costa, C. M., Porter, B., Halliday, B. P., Rinaldi, C. A., Prasad, S. K., Plank, G., Ismail, T. F., & Bishop, M. J. (2020) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2020.2976924 · Cited by 18
A computational investigation into rate-dependant vectorcardiogram changes due to specific fibrosis patterns in non-ischæmic dilated cardiomyopathy
Gemmell, P. M., Gillette, K. K., Balaban, G., Rajani, R., Vigmond, E. J., Plank, G., & Bishop, M. J. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.103895 · Cited by 18
Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis
Barra, S., Providencia, R. A., Duehmke, R. M., Bovéda, S., Begley, D., Grace, A. A., Narayanan, K., TANG, A. S. L., Marijon, É., & Agarwal, S. (2017) · EP Europace · doi:10.1093/europace/eux094 · Cited by 18
Arrhythmia-induced cardiomyopathy: focus on atrial fibrillation
Fabritz, L., Hatem, S. N., & Sossalla, S. T. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01195-2 · Cited by 18
Recent advances in heart failure
Kassi, M., Hannawi, B., & Trachtenberg, B. H. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000497 · Cited by 17
Registro Español de Desfibrilador Automático Implantable. XIV Informe Oficial de la Sección de Electrofisiología y Arritmias de la Sociedad Española de Cardiología (2017)
Lozano, I. F., Osca, J., & Rodríguez, J. A. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.07.027 · Cited by 17
Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines
Edwards, N. C., Price, A. M., Steeds, R. P., Ferro, C. J., & Townend, J. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad011 · Cited by 18
Deep learning-based prediction of major arrhythmic events in dilated cardiomyopathy: A proof of concept study
Corianò, M., Lanera, C., Michieli, L. D., Marra, M. P., Iliceto, S., Gregori, D., & Tona, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297793 · Cited by 18
Implantable Cardioverter Defibrillator and Resynchronization Therapy in Patients With Overt Chronic Kidney Disease
Varga, C. R., Cleland, J. G. F., Abraham, W. T., Lip, G. Y. H., Leyva, F., & Hatamizadeh, P. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.081 · Cited by 17
Verantwortlicher Umgang mit ICDs
Waltenberger, J. L., Schöne-Seifert, B., Friedrich, D. R., Alt‐Epping, B., Bestehorn, M., Dutzmann, J., Ertl, G., Fateh-Moghadam, B., Israel, C. W., & Maase, A. (2017) · Der Kardiologe · doi:10.1007/s12181-017-0185-6 · Cited by 17
Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators
Junttila, J. M., Pelli, A., Kenttä, T. V., Friede, T., Willems, R., Bergau, L., Malík, M., Vandenberk, B., Vos, M. A., Schmidt, G. P., et al. (2019) · Diabetes Care · doi:10.2337/dc19-1014 · Cited by 17
Self-citation
Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation
Higgins, A. Y., Bjerre, J., Parzynski, C. S., Minges, K. E., Ahmad, T., Desai, N. R., Enriquez, A. D., Spatz, E. S., Friedman, D. J., Curtis, J. P., et al. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.07.035 · Cited by 17
Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction
Patel, P. A., Nadarajah, R., Ali, N., Gierula, J., & Witte, K. K. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10017-1 · Cited by 17
Robust Rank Aggregation and Least Absolute Shrinkage and Selection Operator Analysis of Novel Gene Signatures in Dilated Cardiomyopathy
Ma, X., Mo, C., Huang, L., Cao, P., Shen, L., & Gui, C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.747803 · Cited by 17
Late Gadolinium Enhancement and the Risk of Ventricular Arrhythmias and Sudden Death in NYHA Class I Patients with Non-Ischaemic Cardiomyopathy
Marco, A. D., Brown, P. F., Mateus-Porta, G., Faga, V., Nucifora, G., Claver, E., Viedma, J., Galvan, F., Bradley, J., Dallaglio, P., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2793 · Cited by 17
Survival and Heart Failure Hospitalization in Patients With Cardiac Resynchronization Therapy With or Without a Defibrillator for Primary Prevention in Japan ― Analysis of the Japan Cardiac Device Treatment Registry Database ―
Yokoshiki, H., Shimizu, A., Mitsuhashi, T., Furushima, H., Sekiguchi, Y., Manaka, T., Nishii, N., Ueyama, T., Morita, N., Okamura, H., et al. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0234 · Cited by 17
Precision medicine for cardiovascular disease
Sedaghat‐Hamedani, F., Katus, H. A., & Meder, B. (2017) · Herz · doi:10.1007/s00059-017-4667-x · Cited by 18
A clinical approach to arrhythmias revisited in 2018
Jordaens, L. J. L. M. (2018) · Netherlands Heart Journal · doi:10.1007/s12471-018-1089-1 · Cited by 17
Meta-analysis: mistake or milestone in medicine?
Foroutan, F., Guyatt, G. H., Alba, A. C., & Ross, H. J. (2018) · Heart · doi:10.1136/heartjnl-2018-313042 · Cited by 17
Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients—a systematic review and meta-analysis
Siddiqui, W. J., Aggarwal, S., Rafique, M., Singh, S., Kutalek, S., & Eisen, H. J. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9671-6 · Cited by 16
Registro Español de Desfibrilador Automático Implantable. XIII Informe Oficial de la Sección de Electrofisiología y Arritmias de la Sociedad Española de Cardiología (2016)
Alzueta, J., & Lozano, I. F. (2017) · Revista Española de Cardiología · doi:10.1016/j.recesp.2017.07.018 · Cited by 16
Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
Rørth, R., Dewan, P., Kristensen, S. L., Jhund, P. S., Petrie, M. C., Køber, L., & McMurray, J. J. V. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01415-z · Cited by 16
Self-citation
Advancing Cardiovascular Diagnostics: The Expanding Role of CMR in Heart Failure and Cardiomyopathies
Parlati, A. L. M., Nardi, E., Marzano, F., Madaudo, C., Santo, M. D., Cotticelli, C., Agizza, S., Abbellito, G. M., Filardi, F. P., Giudice, M. D., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030865 · Cited by 16
Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024
Chinese Society of Cardiology, C. M. A., Chinese College of Cardiovascular Physician, Chinese Heart Failure Association of Chinese Medical Doctor Association, & Editorial Board of Chinese Journal of Cardiology (2025) · Cardiology Discovery · doi:10.1097/cd9.0000000000000146 · Cited by 17
Radiomic Cardiac MRI Signatures for Predicting Ventricular Arrhythmias in Patients With Nonischemic Dilated Cardiomyopathy
Amyar, A., Al-Deiri, D., Sroubek, J., Kiang, A., Ghanbari, F., Nakamori, S., Rodriguez, J., Kramer, D. B., Manning, W. J., Kwon, D. H., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101684 · Cited by 17
Devices for management of sudden cardiac death: Successes, challenges and perspectives
Dagres, N., & Hindricks, G. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.053 · Cited by 16
Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
on behalf of the DO-IT investigators, van Barreveld, M., Dijkgraaf, M. G. W., Hulleman, M., Boersma, L. V. A., Delnoy, P. P. H. M., Meine, M., Tuinenburg, A. E., Theuns, D. A. M. J., van der Voort, P. H., et al. (2017) · Netherlands Heart Journal · doi:10.1007/s12471-017-1016-x · Cited by 16
Implantable cardioverter defibrillator in nonischemic cardiomyopathy: A systematic review and meta‐analysis
Khan, S. U., Ghimire, S., Talluri, S., Rahman, H., Khan, M. U., Nasir, F., & Kaluski, E. (2017) · Journal of Arrhythmia · doi:10.1002/joa3.12017 · Cited by 16
The Contemporary Era of Sudden Cardiac Death and Ventricular Arrhythmias: Basic Concepts, Recent Developments and Future Directions
Haqqani, H. M., Chan, K. H., Kumar, S., Denniss, A. R., & Gregory, A. T. (2018) · Heart Lung and Circulation · doi:10.1016/s1443-9506(18)31972-3 · Cited by 16
Der tragbare Kardioverter/Defibrillator (WCD) – Indikationen und Einsatz
Deneke, T., Bosch, R., Eckardt, L., Nowak, B., SCHWAB, J. O., Sommer, P., Veltmann, C., & Helms, T. M. (2019) · Der Kardiologe · doi:10.1007/s12181-019-0331-4 · Cited by 16
Scar shape analysis and simulated electrical instabilities in a non-ischemic dilated cardiomyopathy patient cohort
Balaban, G., Halliday, B. P., Bai, W., Porter, B., Malvuccio, C., Lamata, P., Rinaldi, C. A., Plank, G., Rueckert, D., Prasad, S. K., et al. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007421 · Cited by 16
Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality
Mattsson, G., & Magnusson, P. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13869 · Cited by 16
Usefulness of Serum Free Thyroxine Concentration to Predict Ventricular Arrhythmia Risk in Euthyroid Patients With Structural Heart Disease
Müller, P., Dietrich, J. W., Lin, T., Bejinariu, A., Binneboessel, S., Bergen, F., Schmidt, J., Müller, S.-K., Chatzitomaris, A., Kurt, M. M., et al. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.01.019 · Cited by 16
Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure
Dashwood, A. M., Cheesman, E., Beard, N. A., Haqqani, H. M., Wong, Y. W., & Molenaar, P. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00003 · Cited by 16
Clinical impact of defibrillation testing in a real‐world S‐ICD population: Data from the ELISIR registry
Ricciardi, D., Ziacchi, M., Gasperetti, A., Schiavone, M., Picarelli, F., Diemberger, I., Bontempi, L., Belardino, N. D., Bisignani, G., Bonis, S. D., et al. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14833 · Cited by 16
Long‐Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter‐Defibrillator: UMBRELLA Study Final Results
Figuero, S. B., Garcı́a-Alberola, A., Rubio, J., Segura, J. M., Rodríguez, A., Peinado, R., Alzueta, J., Martínez-Ferrer, J., Viñolas, X., de la Concha, J. F., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018108 · Cited by 16
Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease: A prospective propensity score–matched analysis from the Nippon Storm Study
Kondo, Y., Noda, T., Sato, Y., Ueda, M., Nitta, T., Aizawa, Y., Ohe, T., & Kurita, T. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.12.020 · Cited by 16
Impact of QRS duration on left ventricular remodelling and survival in patients with heart failure
Straw, S., McGinlay, M., Gierula, J., Lowry, J. E., Paton, M. F., Cole, C. A., Drozd, M., Koshy, A. O., Müllens, W., Cubbon, R. M., et al. (2021) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001231 · Cited by 16
Arrhythmic risk stratification in non-ischemic dilated cardiomyopathy: Where do we stand after DANISH?
Dilaveris, P., Antoniou, C. K., & Gatzoulis, K. A. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.06.003 · Cited by 16
Sudden Cardiac Death Risk Prediction: The Role of Cardiac Magnetic Resonance Imaging
van der Bijl, P., Podlesnikar, T., Bax, J. J., & Delgado, V. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.05.019 · Cited by 16
Heart Failure
Wu, A. H. (2018) · Annals of Internal Medicine · doi:10.7326/aitc201806050 · Cited by 16
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry.
Villaschi, A., Pagnesi, M., Stolfo, D., Baldetti, L., Lombardi, C., Adamo, M., Loiacono, F., Sammartino, A., Colombo, G., Tomasoni, D., et al. (2023) · American Journal of Cardiology · doi:10.1016/j.amjcard.2023.07.114 · Cited by 14
Current Insights and Novel Cardiovascular Magnetic Resonance-Based Techniques in the Prognosis of Non-Ischemic Dilated Cardiomyopathy
Perone, F., Dentamaro, I., Mura, L. L., Alifragki, A., Marketou, M. E., Cavarretta, E., Papadakis, M., & Androulakis, E. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041017 · Cited by 15
Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients—A systematic review and meta-analysis
Bergau, L., Tichelbäcker, T., Kessel, B., Lüthje, L., Fischer, T. H., Friede, T., & Zabel, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186387 · Cited by 14
The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure
Adam, R. D., Shambrook, J. S., & Flett, A. S. (2017) · Cardiac failure review · doi:10.15420/cfr.2017:19:1 · Cited by 15
Implantable Cardioverter–Defibrillators in Trials of Drug Therapy for Heart Failure: A Systematic Review and Meta‐Analysis
Gama, F. F., Ferreira, J., Carmo, J., Costa, F. M., Carvalho, S., Carmo, P., Cavaco, D., Morgado, F. B., Adragão, P., & Mendes, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015177 · Cited by 12
Registro Español de Desfibrilador Automático Implantable. XVII Informe Oficial de la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología (2020)
Lozano, I. F., Osca, J., & Rodríguez, J. A. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.07.003 · Cited by 15
Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance
Sabouret, P. F., Attias, D., Beauvais, C., Berthelot, E., Bouleti, C., Gibault‐Genty, G., Galat, A., Hanon, O., Hulot, J., Isnard, R., et al. (2021) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2021.05.004 · Cited by 16
Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
Guglielmo, M., & Pontone, G. (2021) · European Heart Journal Supplements · doi:10.1093/eurheartj/suab105 · Cited by 15
Registro Español de Desfibrilador Automático Implantable. XVI Informe Oficial de la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología (2019)
Lozano, I. F., Osca, J., & Rodríguez, J. A. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.07.032 · Cited by 15
Should Nonischemic CRT Candidates Receive CRT-P or CRT-D? ∗
Levy, W. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.044 · Cited by 15
Conventional and right‐sided screening for subcutaneous ICD in a population with congenital heart disease at high risk of sudden cardiac death
Alonso, P., Osca, J., Rueda, J., Cano, Ó., Pimenta, P. M., Andres, A., Sancho, M. J., & Martínez‐Dolz, L. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12461 · Cited by 15
Implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a meta-analysis of randomized controlled trials
Masri, A., Hammadah, M., ADELSTEIN, E. C., Jain, S. K., & Saba, S. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.06.06 · Cited by 15
Effect of Optimization of Medical Treatment on Long-Term Survival of Patients With Heart Failure After Implantable Cardioverter Defibrillator and Cardiac Resynchronization Device Implantation (from the French National EGB Database)
Massoullié, G., Chenaf, C., Mulliez, A., Rossignol, P., Ploux, S., Pereira, B., Reuillard, A., Jean, F., Andronache, M., Eschalier, A., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.12.013 · Cited by 15
Left ventricular ejection fraction for risk stratification in chronic systolic heart failure
Aimo, A., Januzzi, J. L., Vergaro, G., Petersen, C., Pasanisi, E. M., Molinaro, S., Passino, C., & Emdin, M. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.07.117 · Cited by 15
What’s new in heart failure therapy 2018?†
Westphal, J. G., Bekfani, T., & Schulze, P. C. (2018) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivy282 · Cited by 15
Imaging for sudden cardiac death risk stratification: Current perspective and future directions
van der Bijl, P., Delgado, V., & Bax, J. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.04.005 · Cited by 15
Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction
Tseng, A. S., Kunze, K. L., Lee, J. Z., Amin, M., Neville, M. R., Almader‐Douglas, D., Killu, A. M., Madhavan, M., Cha, Y., Asirvatham, S. J., et al. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006951 · Cited by 14

Authors: Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., Eiskjær, H., Brandes, A., Thøgersen, A. M., Gustafsson, F., Egstrup, K., Videbæk, R., Hassager, C., Svendsen, J. H., Høfsten, D. E., Torp-Pedersen, C., & Pehrson, S.
Affiliations: University of Copenhagen (DK)
ORCID: Køber, Lars
Thune, Jens J.
Nielsen, Jens C.
Videbæk, Lars
Steffensen, Flemming H.
Bruun, Niels E.
Eiskjær, Hans
Brandes, Axel
Thøgersen, Anna M.
Gustafsson, Finn
Egstrup, Kenneth
Hassager, Christian
Svendsen, Jesper H.
Høfsten, Dan E.
Torp-Pedersen, Christian
Pehrson, Steen
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2016-09-29
Volume: 375
Issue: 13
Pages: 1221-1230
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1608029
OpenAlex: W2518530324
Cited by: 1,763
References: 18
Citations by year: 2026: 104 · 2025: 138 · 2024: 139 · 2023: 170 · 2022: 182 · 2021: 177 · 2020: 196 · 2019: 212 · 2018: 200 · 2017: 213 · 2016: 28
FWCI: 179.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, other-oa)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Scopus (Elsevier) (submittedVersion)
VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
Funders: Bristol-Myers Squibb
Pfizer
AstraZeneca
Sanofi
Gilead Sciences
Hjerteforeningen
Boston Scientific Corporation
TrygFonden
Servier
St. Jude Medical
Biosense Webster
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: implantable cardioverter-defibrillator, prophylactic ICD, heart failure with reduced ejection fraction, non-ischemic heart failure, sudden cardiac death, all-cause mortality, cardiac resynchronization therapy, device-related infection, left ventricular ejection fraction, DANISH trial
MeSH terms: Aged, Cardiac Pacing, Artificial, Cardiovascular Diseases, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mortality, Stroke Volume, Death, Sudden, Cardiac, Defibrillators, Implantable, Heart Failure, Systolic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks